Board of Pharmacy Specialties (BPS) · Verified for 2026-10-11: BPS BCOP Examination Specifications, effective January 2024; ECO creation date February 2022. BPS currently links this document for 2025 administrations and onward and lists a future outline anticipated for August 2027. The workbook label 'Board Certified Oncology Pharmacist (BCOP) Examination' maps to the official Oncology Pharmacy specialty certification examination, which awards the BPS Board-Certified Oncology Pharmacist credential. The assigned slug is preserved.

This original 20-question sample covers selected topics across the outline. It does not reproduce official exam questions or cover every tested topic.

• BPS Oncology Pharmacy Specialty Certification
• BPS Examination Content Outlines
• BCOP Examination Specifications — Effective January 2024
• NCI Tumor Markers
• NCI Definition of Philadelphia Chromosome
• NCI BRCA Gene Changes: Cancer Risk and Genetic Testing
• NCI Genetic Testing for Inherited Cancer Risk
• CDC HPV Vaccine Recommendations
• NCI Biomarker Testing for Cancer Treatment
• NCI Tumor Grade
• NCI Palliative Care in Cancer
• FDA Safety Labeling Update for Capecitabine and Fluorouracil: DPD Deficiency
• Elitek (Rasburicase) Prescribing Information
• NCI Infection and Neutropenia during Cancer Treatment
• NCI Gastrointestinal Complications — Health Professional PDQ
• NCI Immunotherapy Side Effects
• eviQ Carboplatin Dose Calculator
• 2023 MASCC and ESMO Guideline Update for Prevention of Chemotherapy- and Radiotherapy-Induced Nausea and Vomiting
• ISMP Targeted Medication Safety Best Practices for Hospitals — Frequently Asked Questions, 2026
• NCI Financial Toxicity and Cancer Treatment — Patient PDQ
• Cochrane Handbook, Chapter 15: Interpreting Results and Drawing Conclusions
• Cochrane Handbook, Chapter 6: Choosing Effect Measures and Computing Estimates
• FDA 9 Things to Know About Biosimilars and Interchangeable Biosimilars
• NIOSH Managing Hazardous Drug Exposures: Information for Healthcare Settings
• NCI Understanding Cancer Research Consent Forms
• NCI How Do Clinical Trials Work?
• NCI Are Clinical Trials Safe?
• FDA Risk Evaluation and Mitigation Strategies
• NCI Chemotherapy to Treat Cancer
• NCI Stem Cell and Bone Marrow Transplants for Cancer
• NCI Cancer Therapy Interactions With Foods and Dietary Supplements — Health Professional PDQ
• NCI Follow-Up Medical Care
• NCI Female Fertility and Cancer Treatment
• NHLBI Sickle Cell Disease — Treatment
• NCI Hormone Therapy for Breast Cancer
• DailyMed TAGRISSO (Osimertinib) Prescribing Information
• NCI Non-Small Cell Lung Cancer Treatment — Health Professional PDQ
• DailyMed Imatinib Mesylate Prescribing Information
• NCI Chronic Myeloid Leukemia Treatment — Health Professional PDQ
• ASH Clinical Practice Guidelines on Immune Thrombocytopenia
• ASH 2026 ITP Guidelines: Summary of Changes
• ASH 2026 ITP Guidelines: Visual Summary